DANA HAMMONDS: Open Payments
NPI 1750874020 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 52 payments from 6 companies in 2025. Trend: 2023 $1,286 · 2024 $1,584 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 19 | $498 |
| Gilead Sciences, Inc. | 16 | $440 |
| ABBVIE INC. | 12 | $139 |
| Merck Sharp & Dohme LLC | 3 | $84 |
| Astellas Pharma US Inc | 1 | $25 |
| Invivyd Inc | 1 | $22 |
Products named: DOVATO, DALVANCE, APRETUDE, EMBLAVEO, CABENUVA, PIFELTRO, PREVYMIS, Cresemba.
Industry payments across CO — which companies pay providers there.
